In a world where obesity is often seen as a cosmetic or metabolic concern, new scientific evidence is bringing attention to its deeper and more dangerous implications. According to Prof. Dr. Hüseyin Beğenik, a leading internal medicine expert in Türkiye, obesity poses not only a risk for chronic diseases like diabetes and cardiovascular conditions, but also for certain forms of cancer—most notably gastric cancer.
His recent research, conducted with a dedicated team of Turkish scientists, is gaining international recognition after being published in the esteemed Archives of Medical Science journal. The study highlights a potential biological link between obesity, elevated leptin levels, insulin resistance, and the progression of stomach cancer.
Obesity as a Carcinogenic Risk
Prof. Dr. Beğenik emphasizes that obesity should not be reduced to a matter of physical appearance or limited to its well-known links to diabetes and heart disease. Instead, it must be recognized as a complex metabolic disorder that influences various hormonal, inflammatory, and cellular processes in the body.
“New scientific findings show that obesity has a close association with certain types of cancer. The connection between obesity and deadly illnesses like gastric cancer has raised red flags among researchers and public health experts alike,” Prof. Beğenik noted in a recent press statement.
The Role of Leptin: A Hormone Beyond Appetite
The study, titled “Serum leptin levels in gastric cancer patients and the relationship with insulin resistance”, delves into the biological underpinnings of this connection. Leptin—a hormone secreted by fat cells that signals satiety to the brain—was traditionally seen as a regulator of appetite. But in recent years, its role has expanded.
“Leptin is not just a signal to stop eating. It also plays critical roles in immune function, cell proliferation, and inflammation,” explains Prof. Dr. Beğenik. These factors are increasingly believed to influence how cancer cells grow and spread.
Key Findings: Elevated Leptin in Gastric Cancer Patients
The research team observed that gastric cancer patients exhibited significantly higher leptin levels in their blood compared to healthy individuals. This discrepancy was not just a correlation—it hinted at a potential causative link.
“We discovered that the elevation in leptin levels could be directly related to insulin resistance. Our data suggest that leptin may support tumor cell growth and metastasis,” Prof. Beğenik stated.
This hypothesis aligns with global studies that point to the pro-inflammatory and pro-angiogenic effects of leptin, both of which are mechanisms that could feed cancer progression.
Insulin Resistance: The Missing Link?
One of the most intriguing aspects of the study is its emphasis on insulin resistance as a critical component in this chain. Obesity is known to cause insulin resistance—a condition in which cells fail to respond to insulin effectively, leading to metabolic dysfunctions. This imbalance creates an environment conducive to chronic inflammation, cellular mutation, and other cancer-friendly conditions.
The combination of elevated leptin levels and insulin resistance might form a biological bridge connecting obesity to gastric cancer. As Prof. Dr. Beğenik put it: “Our research is one of the few studies to scientifically demonstrate how these two mechanisms may work together to increase the risk of stomach cancer.”
Not Just Weight Loss: Monitoring Metabolic Health Is Essential
Importantly, the study cautions against the oversimplification of obesity treatment. Prof. Dr. Beğenik underlines that weight loss alone is not enough. Instead, ongoing monitoring of hormonal and metabolic indicators—particularly leptin levels and insulin sensitivity—should be integrated into routine preventive care.
“Detecting hormonal imbalances early, and managing metabolic irregularities like insulin resistance, could serve as a powerful strategy in cancer prevention,” he noted.
This insight is especially valuable in a time when many health strategies focus heavily on diet and exercise, often overlooking the underlying biochemical shifts that contribute to chronic disease.
Obesity: A Public Health Concern, Not Just an Individual Problem
The findings also shed light on the societal dimensions of obesity. According to Prof. Dr. Beğenik, obesity has evolved into a major public health issue in Türkiye and globally, affecting not only individual wellbeing but also national healthcare systems.
“In the fight against obesity, we must consider more than just numbers on a scale. Metabolic health markers and early diagnostic strategies must be part of the conversation,” he emphasized.
Call for Proactive Health Strategies
One of the most critical messages from Prof. Dr. Beğenik’s research is the importance of a proactive, rather than reactive, approach to healthcare. Preventing disease before it manifests requires:
Regular blood screenings to monitor leptin levels
Early detection and treatment of insulin resistance
Public awareness campaigns about the hidden risks of obesity
Training healthcare providers to look beyond BMI and consider metabolic profiles
“Our study makes it clear: prevention is not just about diet or exercise. It’s about understanding and managing the body’s hormonal and metabolic systems before disease takes hold,” Prof. Dr. Beğenik concluded.
Implications for Future Cancer Research
The study has opened doors for further exploration into how hormones like leptin interact with cancer pathways. While much remains to be discovered, the results offer a promising direction for integrating endocrinology and oncology.
Health authorities in Türkiye and abroad may soon consider routine leptin testing for high-risk individuals, especially those struggling with obesity and insulin resistance. By flagging elevated levels early, it may be possible to intervene before cancer risk becomes reality.
Toward a Broader Understanding of Obesity
In redefining obesity not just as a weight issue, but as a multi-layered metabolic and hormonal condition, Prof. Dr. Beğenik’s research contributes to a growing movement in global health. It challenges both the medical community and the public to expand their perspective and treat obesity as a whole-body disorder with far-reaching consequences.
As the data continue to accumulate, one message rings clear: true prevention must be holistic, hormonal, and early.
